Flynn DC - Search Results

1

Summy JM, Sudol M, Eck MJ, Monteiro AN, Gatesman A, Flynn DC. Summy JM, et al. Among authors: flynn dc. Front Biosci. 2003 Jan 1;8:s185-205. doi: 10.2741/1011. Front Biosci. 2003. PMID: 12456296 Review.

2

The effects of phosphorylation on adaptor protein function.

Cherezova L, Gatesman A, Flynn DC. Cherezova L, et al. Among authors: flynn dc. Front Biosci. 2002 Jan 1;7:d164-203. doi: 10.2741/cherezov. Front Biosci. 2002. PMID: 11779691 Review.

3

The SH4-Unique-SH3-SH2 domains dictate specificity in signaling that differentiate c-Yes from c-Src.

Summy JM, Qian Y, Jiang BH, Guappone-Koay A, Gatesman A, Shi X, Flynn DC. Summy JM, et al. Among authors: flynn dc. J Cell Sci. 2003 Jun 15;116(Pt 12):2585-98. doi: 10.1242/jcs.00466. Epub 2003 May 6. J Cell Sci. 2003. PMID: 12734402

4

c-Yes response to growth factor activation.

Clump DA, Qazi IH, Sudol M, Flynn DC. Clump DA, et al. Among authors: flynn dc. Growth Factors. 2005 Dec;23(4):263-72. doi: 10.1080/08977190500199360. Growth Factors. 2005. PMID: 16338789 Review.

5

The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.

Summy JM, Guappone AC, Sudol M, Flynn DC. Summy JM, et al. Among authors: flynn dc. Oncogene. 2000 Jan 6;19(1):155-60. doi: 10.1038/sj.onc.1203265. Oncogene. 2000. PMID: 10644991

6

Chimeric constructs containing the SH4/Unique domains of cYes can restrict the ability of Src(527F) to upregulate heme oxygenase-1 expression efficiently.

Hoey JG, Summy J, Flynn DC. Hoey JG, et al. Among authors: flynn dc. Cell Signal. 2000 Oct;12(9-10):691-701. doi: 10.1016/s0898-6568(00)00116-9. Cell Signal. 2000. PMID: 11080622

7

Protein kinase Calpha activates c-Src and induces podosome formation via AFAP-110.

Gatesman A, Walker VG, Baisden JM, Weed SA, Flynn DC. Gatesman A, et al. Among authors: flynn dc. Mol Cell Biol. 2004 Sep;24(17):7578-97. doi: 10.1128/MCB.24.17.7578-7597.2004. Mol Cell Biol. 2004. PMID: 15314167 Free PMC article.

8

Monoclonal antibodies directed against AFAP-110 recognize species-specific and conserved epitopes.

Qian Y, Guappone AC, Baisden JM, Hill MW, Summy JM, Flynn DC. Qian Y, et al. Among authors: flynn dc. Hybridoma. 1999 Apr;18(2):167-75. doi: 10.1089/hyb.1999.18.167. Hybridoma. 1999. PMID: 10380016

9

The intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinases.

Baisden JM, Gatesman AS, Cherezova L, Jiang BH, Flynn DC. Baisden JM, et al. Among authors: flynn dc. Oncogene. 2001 Oct 4;20(45):6607-16. doi: 10.1038/sj.onc.1204802. Oncogene. 2001. PMID: 11641786

10

PC phosphorylation increases the ability of AFAP-110 to cross-link actin filaments.

Qian Y, Baisden JM, Cherezova L, Summy JM, Guappone-Koay A, Shi X, Mast T, Pustula J, Zot HG, Mazloum N, Lee MY, Flynn DC. Qian Y, et al. Among authors: flynn dc. Mol Biol Cell. 2002 Jul;13(7):2311-22. doi: 10.1091/mbc.e01-12-0148. Mol Biol Cell. 2002. PMID: 12134071 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page